URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Yuhchyau Chen

Concepts (269)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Carcinoma, Non-Small-Cell Lung
12
2001
66
4.780
Why?
Lung Neoplasms
13
2001
422
4.240
Why?
Reticulocytes
8
2003
46
4.020
Why?
Paclitaxel
6
2001
56
2.270
Why?
Micronuclei, Chromosome-Defective
4
2007
21
2.200
Why?
Radiation-Sensitizing Agents
5
2001
72
2.170
Why?
Radiation Pneumonitis
6
2001
37
1.660
Why?
Neoplasms
8
2003
701
1.590
Why?
Gamma Rays
3
2009
65
1.470
Why?
Thoracic Neoplasms
4
2001
17
1.360
Why?
Antineoplastic Agents, Phytogenic
3
2003
38
1.300
Why?
Bone Marrow Cells
2
2009
220
1.280
Why?
Micronucleus Tests
6
2003
25
1.240
Why?
Flow Cytometry
12
1988
597
1.120
Why?
Dose-Response Relationship, Radiation
9
2003
205
1.000
Why?
Fibroblast Growth Factor 7
2
2011
11
0.990
Why?
Radiation Injuries, Experimental
3
2005
82
0.940
Why?
Whole-Body Irradiation
4
1999
78
0.930
Why?
Interleukin-6
4
2001
314
0.840
Why?
Chemoradiotherapy
1
2012
1
0.800
Why?
Radiation Oncology
2
2006
17
0.790
Why?
Middle Aged
22
2001
9461
0.790
Why?
Deglutition Disorders
1
2012
20
0.790
Why?
Laryngeal Neoplasms
1
2011
18
0.760
Why?
Aged
17
2001
6986
0.750
Why?
Chromosome Aberrations
3
2003
114
0.740
Why?
Radiotherapy
5
2003
179
0.730
Why?
Aged, 80 and over
12
2001
2423
0.720
Why?
Combined Modality Therapy
5
2003
459
0.720
Why?
Taxoids
1
2010
14
0.720
Why?
Cell Cycle
9
1988
247
0.690
Why?
Female
27
1988
19061
0.690
Why?
Adult
22
1988
10906
0.690
Why?
Radiometry
1
2010
39
0.690
Why?
Radiotherapy Dosage
9
2001
185
0.680
Why?
Biological Assay
1
2010
68
0.670
Why?
Carcinoma, Squamous Cell
1
2011
230
0.670
Why?
Pneumonectomy
2
2008
13
0.660
Why?
Humans
41
1988
35000
0.660
Why?
Neoplastic Stem Cells
1
2009
40
0.650
Why?
Palliative Care
2
2010
151
0.640
Why?
Radiation Injuries
3
2006
123
0.640
Why?
Male
24
1988
18870
0.640
Why?
Clinical Trials as Topic
2
2004
664
0.590
Why?
Biological Markers
6
2001
532
0.590
Why?
Cesium Radioisotopes
1
2007
27
0.580
Why?
Biomedical Research
1
2009
132
0.570
Why?
Treatment Outcome
10
2008
2487
0.570
Why?
Automation
1
2006
31
0.550
Why?
Interleukin-1
2
2002
204
0.550
Why?
Nuclear Energy
1
2006
3
0.530
Why?
Radiobiology
1
2006
9
0.530
Why?
International Agencies
1
2006
7
0.530
Why?
Cytokines
3
2002
555
0.480
Why?
Dose Fractionation
4
2009
57
0.430
Why?
Mice
11
1990
5900
0.420
Why?
Antineoplastic Combined Chemotherapy Protocols
3
2009
409
0.410
Why?
Genetic Testing
1
2003
92
0.410
Why?
Drug Administration Schedule
3
2001
362
0.400
Why?
Oxygen
1
2005
476
0.390
Why?
Neoplasm Staging
4
2008
326
0.370
Why?
Platelet-Derived Growth Factor
3
1989
105
0.370
Why?
Epidermal Growth Factor
3
1989
106
0.370
Why?
Neoplasms, Experimental
1
2001
146
0.370
Why?
Animals
15
1990
15647
0.360
Why?
Severity of Illness Index
3
2006
878
0.360
Why?
Genetic Predisposition to Disease
1
2003
306
0.360
Why?
Bioreactors
2
2009
8
0.350
Why?
Somatomedins
2
1989
13
0.350
Why?
Follow-Up Studies
4
2001
1757
0.330
Why?
Insulin-Like Growth Factor I
2
1989
98
0.320
Why?
Retrospective Studies
6
2008
2167
0.320
Why?
Head and Neck Neoplasms
2
2007
78
0.320
Why?
Cells, Cultured
7
1988
2367
0.300
Why?
Cell Survival
2
1990
537
0.300
Why?
Antineoplastic Agents
5
2003
598
0.300
Why?
Radiosurgery
2
2009
73
0.300
Why?
Tumor Necrosis Factor-alpha
2
2001
627
0.300
Why?
DNA Damage
4
2003
168
0.280
Why?
Fibroblasts
3
1988
514
0.280
Why?
Enzyme-Linked Immunosorbent Assay
3
2001
459
0.280
Why?
Mitosis
2
1990
99
0.280
Why?
Cisplatin
3
2009
93
0.260
Why?
Mice, Inbred C57BL
3
2009
1613
0.260
Why?
Survival Rate
4
2009
584
0.260
Why?
Tumor Cells, Cultured
3
2001
871
0.250
Why?
Sensitivity and Specificity
2
2005
866
0.230
Why?
Time Factors
5
1989
3047
0.230
Why?
Tumor Markers, Biological
2
2003
221
0.230
Why?
Proportional Hazards Models
3
2008
398
0.230
Why?
Pyrazoles
2
2003
56
0.220
Why?
Tomography, X-Ray Computed
3
2003
729
0.220
Why?
Receptors, Thrombopoietin
1
2012
7
0.200
Why?
Hydrazines
1
2012
13
0.200
Why?
Survival Analysis
2
2011
575
0.200
Why?
Benzoates
1
2012
15
0.200
Why?
Disease Progression
2
2009
496
0.200
Why?
Double-Blind Method
2
2011
985
0.200
Why?
Skin
2
1989
370
0.200
Why?
Carboplatin
1
2012
29
0.200
Why?
Population
1
2011
10
0.190
Why?
Stomatitis
1
2011
15
0.190
Why?
Thrombocytopenia
1
2012
71
0.190
Why?
Disease-Free Survival
1
2012
191
0.190
Why?
Kaplan-Meier Estimate
1
2012
190
0.190
Why?
Recombinant Proteins
2
2010
706
0.190
Why?
SEER Program
1
2011
51
0.190
Why?
Culture Media
2
1988
190
0.190
Why?
Stem Cell Transplantation
1
2012
108
0.180
Why?
Erythroid Cells
1
2011
24
0.180
Why?
Tumor Stem Cell Assay
1
2010
22
0.180
Why?
Magnetic Resonance Spectroscopy
1
1992
240
0.180
Why?
Bromodeoxyuridine
4
1988
63
0.180
Why?
Nausea
2
2007
153
0.180
Why?
Granulocyte Colony-Stimulating Factor
1
2010
42
0.180
Why?
Neoplasm Recurrence, Local
2
2009
272
0.180
Why?
Remission Induction
1
2010
155
0.180
Why?
Translational Medical Research
1
2010
36
0.170
Why?
Erythropoiesis
1
2010
65
0.170
Why?
Cell Line, Tumor
2
2003
543
0.170
Why?
Neoplastic Cells, Circulating
1
2009
7
0.170
Why?
Radiation Dosage
1
2010
115
0.170
Why?
Information Dissemination
1
2009
24
0.160
Why?
Acupressure
1
2009
16
0.160
Why?
Drug Resistance, Neoplasm
1
2009
54
0.160
Why?
Adrenal Gland Neoplasms
1
2009
35
0.160
Why?
Pilot Projects
1
2010
426
0.160
Why?
Cell Hypoxia
1
2009
88
0.160
Why?
Prospective Studies
2
2001
1606
0.160
Why?
Smoking
2
2008
387
0.150
Why?
Kinetics
2
1988
1377
0.150
Why?
Infusions, Intravenous
1
2008
139
0.150
Why?
Cohort Studies
1
2011
912
0.150
Why?
Quinuclidines
1
2007
6
0.150
Why?
Muscarinic Agonists
1
2007
20
0.150
Why?
Thiophenes
1
2007
18
0.150
Why?
Xerostomia
1
2007
43
0.150
Why?
Hematopoietic Stem Cells
1
2009
196
0.140
Why?
Bisbenzimidazole
3
1988
9
0.140
Why?
Antigens, Differentiation, B-Lymphocyte
2
2003
51
0.140
Why?
Reproducibility of Results
1
2010
859
0.140
Why?
Dictionaries as Topic
1
2006
1
0.130
Why?
New York
1
2010
1191
0.130
Why?
Radiation-Protective Agents
1
2006
38
0.130
Why?
Lung
2
1988
1132
0.130
Why?
Age Factors
1
2009
1060
0.130
Why?
Cell Differentiation
1
2011
1021
0.120
Why?
Antigens, CD
2
2003
240
0.120
Why?
Terminology as Topic
1
2006
104
0.120
Why?
Spectroscopy, Near-Infrared
1
2005
12
0.120
Why?
ROC Curve
1
2005
119
0.120
Why?
History, 21st Century
1
2005
47
0.120
Why?
Apoptosis
3
2003
782
0.120
Why?
Intestines
1
2005
153
0.120
Why?
Research
1
2005
169
0.110
Why?
United States
1
2011
2511
0.110
Why?
History, 20th Century
1
2005
232
0.110
Why?
Anoxia
1
2005
154
0.110
Why?
Information Services
1
2003
19
0.110
Why?
Maximum Tolerated Dose
1
2003
16
0.110
Why?
G2 Phase
1
2003
30
0.110
Why?
Predictive Value of Tests
1
2005
579
0.110
Why?
Cyclooxygenase Inhibitors
1
2003
63
0.110
Why?
Sulfonamides
1
2003
97
0.100
Why?
Surgical Procedures, Operative
1
2003
108
0.100
Why?
Models, Biological
1
2007
982
0.100
Why?
Transplantation, Heterologous
1
2001
89
0.100
Why?
Necrosis
1
2001
99
0.100
Why?
Neoplasm Transplantation
1
2001
188
0.100
Why?
Mesothelioma
1
2001
30
0.100
Why?
Postoperative Complications
1
2006
706
0.090
Why?
Isoenzymes
1
2003
391
0.090
Why?
Risk Factors
2
2002
2172
0.090
Why?
Prognosis
1
2003
1030
0.080
Why?
Transplantation Conditioning
1
1999
33
0.080
Why?
Cyclophosphamide
1
1999
169
0.080
Why?
Fibroblast Growth Factor 2
1
1999
76
0.080
Why?
Bone Marrow Transplantation
1
1999
189
0.070
Why?
Dose-Response Relationship, Drug
2
1990
1085
0.070
Why?
Comorbidity
2
2008
365
0.070
Why?
Breast Neoplasms
1
2003
660
0.070
Why?
Transplantation, Homologous
2
1999
261
0.070
Why?
Ethidium
1
1994
14
0.060
Why?
Receptors, Transferrin
2
2003
19
0.060
Why?
Staining and Labeling
2
1990
161
0.050
Why?
Platelet Count
1
2012
46
0.050
Why?
Tissue Survival
1
1992
5
0.050
Why?
Phosphocreatine
1
1992
12
0.050
Why?
Organophosphorus Compounds
1
1992
22
0.050
Why?
Hydrogen
1
1992
28
0.050
Why?
Transplantation, Autologous
1
2012
136
0.050
Why?
Fatal Outcome
1
2012
101
0.050
Why?
Models, Anatomic
1
1992
38
0.050
Why?
Phosphorus
1
1992
49
0.050
Why?
Intention to Treat Analysis
1
2011
8
0.050
Why?
Drug Toxicity
1
2011
14
0.050
Why?
Cell Separation
2
1988
224
0.050
Why?
BH3 Interacting Domain Death Agonist Protein
1
2011
11
0.050
Why?
Ischemia
1
1992
83
0.050
Why?
Phosphates
1
1992
145
0.050
Why?
Weight Loss
1
2011
63
0.050
Why?
Rats, Inbred F344
1
1992
356
0.050
Why?
bcl-2-Associated X Protein
1
2011
52
0.050
Why?
Rats, Inbred Strains
1
1992
636
0.050
Why?
Diploidy
1
1990
13
0.050
Why?
bcl-X Protein
1
2011
37
0.050
Why?
Equipment Design
1
1992
244
0.050
Why?
Erythroblasts
1
2011
40
0.050
Why?
Surgical Flaps
1
1992
112
0.050
Why?
Mitogens
1
1990
35
0.050
Why?
Rats
2
1992
4185
0.050
Why?
Neoplasm Metastasis
1
2011
219
0.040
Why?
Image Enhancement
1
1992
139
0.040
Why?
Cell Count
1
1990
279
0.040
Why?
Transferrin
1
1989
35
0.040
Why?
Etoposide
1
2009
73
0.040
Why?
Cell Communication
1
1990
135
0.040
Why?
Markov Chains
1
2009
40
0.040
Why?
Recurrence
1
2011
656
0.040
Why?
Tumor Burden
1
2009
22
0.040
Why?
Cell Division
3
1988
735
0.040
Why?
Gastrointestinal Tract
1
2009
26
0.040
Why?
Fluorescent Dyes
1
1990
218
0.040
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2011
513
0.040
Why?
Dexamethasone
1
1989
176
0.040
Why?
Vomiting
1
2009
114
0.040
Why?
Biopsy
1
1989
359
0.040
Why?
Benzimidazoles
1
1988
20
0.040
Why?
Dyspepsia
1
2007
2
0.040
Why?
Sweat
1
2007
7
0.040
Why?
Pulmonary Fibrosis
1
1988
130
0.040
Why?
Diarrhea
1
2007
61
0.040
Why?
Insulin
1
1990
626
0.040
Why?
Logistic Models
1
2009
581
0.030
Why?
Incidence
1
2008
644
0.030
Why?
Algorithms
1
2009
518
0.030
Why?
Transforming Growth Factor beta2
1
2005
4
0.030
Why?
Transforming Growth Factor beta3
1
2005
4
0.030
Why?
Risk Assessment
1
2009
808
0.030
Why?
Kidney
1
2009
581
0.030
Why?
Gene Expression Regulation
1
2011
848
0.030
Why?
Mice, Inbred DBA
1
2005
92
0.030
Why?
Transforming Growth Factor beta1
1
2005
70
0.030
Why?
DNA
1
1990
831
0.030
Why?
Young Adult
1
2009
1013
0.030
Why?
Propidium
1
2004
4
0.030
Why?
Pregnancy
1
1989
1919
0.030
Why?
Cytogenetic Analysis
1
2004
21
0.030
Why?
Splenectomy
1
2003
36
0.030
Why?
Splenic Diseases
1
2003
14
0.030
Why?
Antimetabolites, Antineoplastic
1
2004
38
0.030
Why?
Drug Screening Assays, Antitumor
1
2003
34
0.030
Why?
Fluorouracil
1
2004
77
0.030
Why?
Xenograft Model Antitumor Assays
1
2003
43
0.030
Why?
Cyclooxygenase 2 Inhibitors
1
2003
61
0.030
Why?
Interferon-gamma
1
2005
340
0.030
Why?
Transforming Growth Factor beta
1
2005
362
0.030
Why?
Cyclooxygenase 2
1
2003
211
0.020
Why?
Prostaglandin-Endoperoxide Synthases
1
2003
159
0.020
Why?
Rats, Sprague-Dawley
1
2004
956
0.020
Why?
Membrane Proteins
1
2003
530
0.020
Why?
RNA, Messenger
1
2005
1791
0.020
Why?
Data Display
1
1990
12
0.010
Why?
Reference Standards
1
1990
44
0.010
Why?
Fluorescence
1
1990
71
0.010
Why?
Microcomputers
1
1988
11
0.010
Why?
Fluorescent Antibody Technique
1
1988
287
0.010
Why?
Lymphocytes
1
1988
293
0.010
Why?
Lymphocyte Activation
1
1988
407
0.010
Why?

Visualizations


Chen's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department